Evidence map›Paper›PMID 31085353›Full record

ArticleMolecular therapy. Nucleic acids2019

Synthetic Design of Asymmetric miRNA with an Engineered 3' Overhang to Improve Strand Selection.

Sandeep Kadekar, Ganesh N Nawale, Kira Karlsson, Cecilia Ålander, Oommen P Oommen, Oommen P Varghese

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Sandeep KadekarTranslational Chemical Biology Laboratory, Polymer Chemistry Division, Department of Chemistry, Ångström Laboratory, Uppsala University, 751 21 Uppsala, Sweden.
Ganesh N NawaleTranslational Chemical Biology Laboratory, Polymer Chemistry Division, Department of Chemistry, Ångström Laboratory, Uppsala University, 751 21 Uppsala, Sweden.
Kira KarlssonTranslational Chemical Biology Laboratory, Polymer Chemistry Division, Department of Chemistry, Ångström Laboratory, Uppsala University, 751 21 Uppsala, Sweden.
Cecilia ÅlanderTranslational Chemical Biology Laboratory, Polymer Chemistry Division, Department of Chemistry, Ångström Laboratory, Uppsala University, 751 21 Uppsala, Sweden.
Oommen P OommenBioengineering and Nanomedicine Lab, Faculty of Medicine and Health Technology, Tampere University and BioMediTech Institute, 33720 Tampere, Finland.
Oommen P VargheseTranslational Chemical Biology Laboratory, Polymer Chemistry Division, Department of Chemistry, Ångström Laboratory, Uppsala University, 751 21 Uppsala, Sweden. Electronic address: oommen.varghese@kemi.uu.se.
Uppsala University · SETampere University · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We developed a novel miRNA design that significantly improves strand selection within the RISC complex by engineering the 3' end by adding extra nucleotides. Addition of seven nucleotides at the 3' ends of the miR or miR* strand resulted in a thermodynamic asymmetry at either of the two ends, which resulted in selective RISC recruitment, as demonstrated by a stem-loop PCR experiment. Such selective recruitment was also corroborated at the protein level by western blot analysis. To investigate the functional effect because of selective recruitment, we performed apoptosis and metastasis studies using human colon carcinoma cells (HCT116) and human osteosarcoma cells (MG63). These experiments indicated that recruitment of the miR strand is responsible for inducing apoptosis and inhibiting the invasiveness of cancer cells. Recruitment of the miR* strand, on the other hand, had the opposite effect. To the best of our knowledge, our strand engineering strategy is the first report of improved strand selection of a desired miRNA strand by RISC without using any chemical modifications or mismatches. We believe that such structural modifications of miR34a could mitigate some of the off-target effects of miRNA therapy and would also allow a better understanding of sequence-specific gene regulation. Such a design could also be adapted to other miRNAs to enhance their therapeutic potential.

Indexed as

anticancer therapymiR34amiRNARNAistrand selection

Identifiers

PMID31085353
PMCPMC6517641
OpenAlexW2938348457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.